What is he best known for?
The fields of study he is best known for:
- Bacteria
- Gene
- Antibiotics
Gian Maria Rossolini mainly investigates Microbiology, Klebsiella pneumoniae, Drug resistance, Antibiotic resistance and Antibacterial agent.
His Microbiology research incorporates themes from Pseudomonas aeruginosa, Genetics and Enterobacteriaceae, Escherichia coli.
His research in Klebsiella pneumoniae intersects with topics in Bacterial protein, Internal medicine and Colistin.
The concepts of his Drug resistance study are interwoven with issues in Antibiotics, Infection control, Environmental health, Resistance and Outbreak.
His work in Antibiotic resistance addresses subjects such as Tetracycline, which are connected to disciplines such as Streptomycin.
His research integrates issues of Cephamycins and Neisseriaceae in his study of Antibacterial agent.
His most cited work include:
- CTX-M: changing the face of ESBLs in Europe (732 citations)
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe (614 citations)
- Cloning and Characterization of blaVIM, a New Integron-Borne Metallo-β-Lactamase Gene from a Pseudomonas aeruginosa Clinical Isolate (553 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Microbiology, Klebsiella pneumoniae, Escherichia coli, Genetics and Plasmid.
His Microbiology research is multidisciplinary, incorporating elements of Pseudomonas aeruginosa, Enterobacteriaceae and Gene.
His Pseudomonas aeruginosa research incorporates elements of Antibacterial agent, Beta-lactamase and Integron.
His study in Klebsiella pneumoniae is interdisciplinary in nature, drawing from both Colistin and Virology.
Gian Maria Rossolini has included themes like Cephalosporin and Enzyme in his Escherichia coli study.
His Antibiotic resistance study combines topics from a wide range of disciplines, such as Antimicrobial and Drug resistance.
He most often published in these fields:
- Microbiology (67.86%)
- Klebsiella pneumoniae (26.26%)
- Escherichia coli (18.94%)
What were the highlights of his more recent work (between 2016-2021)?
- Microbiology (67.86%)
- Klebsiella pneumoniae (26.26%)
- Colistin (10.19%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Microbiology, Klebsiella pneumoniae, Colistin, Internal medicine and Antimicrobial.
He combines subjects such as Gene and Avibactam with his study of Microbiology.
Gene is a subfield of Genetics that Gian Maria Rossolini investigates.
His Klebsiella pneumoniae research integrates issues from Plasmid, Lytic cycle, Enterobacteriaceae and Clade.
His Colistin research is multidisciplinary, incorporating perspectives in Tigecycline, Lipid A, Acinetobacter baumannii and Carbapenem.
Gian Maria Rossolini focuses mostly in the field of Antimicrobial, narrowing it down to matters related to Antibiotic resistance and, in some cases, Intensive care medicine.
Between 2016 and 2021, his most popular works were:
- Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. (270 citations)
- Prediction of Susceptibility to First-Line Tuberculosis Drugs by DNA Sequencing. (178 citations)
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (153 citations)
In his most recent research, the most cited papers focused on:
- Bacteria
- Gene
- Antibiotics
Gian Maria Rossolini spends much of his time researching Microbiology, Klebsiella pneumoniae, Colistin, Drug resistance and Antibiotic resistance.
His Microbiology study incorporates themes from Enterobacteriaceae and Virology.
His Klebsiella pneumoniae research is multidisciplinary, incorporating elements of Bacteriophage, Proteus mirabilis, Lytic cycle and Epidemiology.
The Colistin study combines topics in areas such as MCR-1, Tigecycline and Gene, Escherichia coli.
His Drug resistance research includes themes of Mycobacterium tuberculosis complex, Mycobacterium tuberculosis, Isoniazid, Broth microdilution and Klebsiella.
His study in Antibiotic resistance is interdisciplinary in nature, drawing from both Antimicrobial and Public health.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
